Austin Wanda M 4

What Happened
Wanda M. Austin, a director of Amgen Inc., received a grant of 665 restricted stock units (RSUs) on 2026-05-19. The Form 4 reports the acquisition as 665 RSUs at $0.00 (transaction code A). Per the filing, the RSUs vested immediately and are paid in shares on a one-to-one basis; vested RSUs may be deferred by the director under an elected schedule.

Key Details

• Transaction date: 2026-05-19; Filing date: 2026-05-21 (filed within the typical two-business-day Form 4 window).
• Reported acquisition: 665 RSUs at $0.00 (award/grant, code A).
• Shares owned following the transaction: not specified in the filing.
• Footnote: RSUs were granted under the Amgen Inc. 2009 Director Incentive Program (Second Amended and Restated 2009 Equity Incentive Plan); vested RSUs are paid one-for-one in common stock and may be deferred per the director’s election.

Context
This transaction is an award of equity to a non-employee director (a routine form of director compensation). The $0.00 acquisition price reflects the nature of RSU grants (shares are issued upon vesting rather than purchased). Such awards generally do not signal a buy/sell decision by the insider beyond acceptance of standard compensation.